Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary function testing in idiopathic interstitial pneumonias.

Fernando J Martinez1, Kevin Flaherty

  • 1Division of Pulmonary and Critical Care Medicine, Taubman Center 3916, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0360, USA. fmartine@umich.edu

Proceedings of the American Thoracic Society
|June 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Future concepts in bronchodilation for COPD: dual- <i>versus</i> monotherapy.

European respiratory review : an official journal of the European Respiratory Society·2021
Same author

Comparative Impact of Depressive Symptoms and FEV<sub>1</sub>% on Chronic Obstructive Pulmonary Disease.

Annals of the American Thoracic Society·2021
Same author

A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial.

The European respiratory journal·2021
Same author

Barriers to antigen detection and avoidance in chronic hypersensitivity pneumonitis in the United States.

Respiratory research·2021
Same author

Identifying organ dysfunction trajectory-based subphenotypes in critically ill patients with COVID-19.

Scientific reports·2021
Same author

Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial.

ERJ open research·2021
Same journal

Note from the editor.

Proceedings of the American Thoracic Society·2012
Same journal

Adaptation, evaluation, and updating of guidelines: article 14 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Proceedings of the American Thoracic Society·2012
Same journal

Disseminating and implementing guidelines: article 13 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Proceedings of the American Thoracic Society·2012
Same journal

Reporting and publishing guidelines: article 12 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Proceedings of the American Thoracic Society·2012
Same journal

Moving from evidence to developing recommendations in guidelines: article 11 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Proceedings of the American Thoracic Society·2012
Same journal

How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Proceedings of the American Thoracic Society·2012
See all related articles

Pulmonary function testing aids in diagnosing diffuse parenchymal lung diseases and assessing severity. It is valuable for monitoring treatment response and disease progression in patients with these conditions.

Area of Science:

  • Pulmonology
  • Respiratory Medicine

Background:

  • Diffuse parenchymal lung diseases (DPDLs) encompass disorders affecting the interstitial space.
  • Idiopathic interstitial pneumonias are a major subset of DPDLs.
  • DPDLs often present with restrictive ventilatory defects and reduced diffusing capacity (DLCO).

Purpose of the Study:

  • To evaluate the role of pulmonary function testing in the assessment and management of DPDLs.
  • To determine the utility of physiologic testing in diagnosis, severity assessment, prognosis, and monitoring of DPDLs.

Main Methods:

  • Review of the application of pulmonary function testing in DPDLs.
  • Analysis of spirometry and DLCO measurements for diagnostic and prognostic value.

Main Results:

Related Experiment Videos

  • Pulmonary function testing aids in DPDL diagnosis, though differential diagnosis value is limited.
  • DLCO is crucial for assessing severity and prognosis in conditions like idiopathic pulmonary fibrosis.
  • Exertional desaturation and FVC changes predict mortality risk.
  • Physiologic testing effectively monitors therapeutic response and disease progression.

Conclusions:

  • Pulmonary function testing, including spirometry and DLCO, is integral to managing DPDLs.
  • Physiologic parameters provide critical insights into disease severity, prognosis, and treatment efficacy.